RVX Chart by TradingView

Business Description

Resverlogix is a biotechnology company focused on the two largest drug markets – cancer and cholesterol. Its unique technology is focused on increasing HDL’s (good cholesterol) as opposed to the more common focus of lowering LDL’s (bad cholesterol).

Website: http://www.resverlogix.com/


Resverlogix Announces Management Change Jul. 6, 2021
How Much Of Resverlogix Corp. (TSE:RVX) Do Institutions Own? Jul. 2, 2021
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer Jun. 24, 2021
Resverlogix Announces Voting Results from the 2021 Meeting of Shareholders Jun. 23, 2021
Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in the United States and Canada Jun. 3, 2021